Crispr Therapeutics shares owned by E Fund Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by E Fund Management
from 13F filings
Historical chart of E Fund Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by E Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by E Fund Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $621k | 13k | 48.64 |
| 2025-03-31 | $464k | 14k | 34.03 |
| 2024-12-31 | $464k | 12k | 39.36 |
| 2024-09-30 | $645k | 14k | 46.98 |
| 2024-06-30 | $599k | 11k | 54.01 |
| 2024-03-31 | $374k | 5.5k | 68.16 |
| 2023-12-31 | $592k | 9.5k | 62.60 |
| 2023-09-30 | $416k | 9.2k | 45.43 |
| 2023-06-30 | $409k | 7.3k | 56.07 |
| 2023-03-31 | $404k | 8.9k | 45.21 |
| 2022-12-31 | $351k | 8.6k | 40.68 |
| 2022-09-30 | $465k | 7.1k | 65.37 |
| 2022-06-30 | $417k | 6.9k | 60.72 |